CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net loss	$ (8,704,757)	$ (2,409,905)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	20,995	98,374
Fair value of vested options issued to officers, directors and employees	417,866	785,719
Loss from change in fair value of warrant liability	6,332,599
Amortization of capitalized financing costs		82,084
Amortization of debt discount attributable to convertible debentures		507,478
Equity based compensation	13,238	1,363
Common stock issued in settlement of interest		114,411
Change in operating assets and liabilities:
Increase in accounts receivable	(64,788)	(24,024)
Decrease in prepaid expenses and deposits	27,682	13,868
Increase in accounts payable and accrued liabilities	216,793	19,117
Net cash used in operating activities	(1,740,372)	(811,515)
Cash flows from investing activities:
Net cash used in investing activities
Cash flows from financing activities:
Net proceeds from sale of common stock	2,000,000
Net cash provided by financing activities	2,000,000
Net increase (decrease) in cash and cash equivalents	259,628	(811,515)
Cash and cash equivalents at beginning of period	724,782	2,747,294
Cash and cash equivalents at end of period	984,410	1,935,779
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing activities:
Common stock issued in exchange for previously incurred debt		$ 1,150,000